31 January 2022>: Meta-Analysis
Utility of Pretreatment Blood Platelet-To-Lymphocyte Ratio in Prediction of Clinical Outcomes and Chemosensitivity in Patients with Advanced Gastric Cancer: A Meta-Analysis
Xiulan Peng 1AE* , Wei Zeng 2BF* , Bing Tang 3CF* , Anbing He 1B , Min Zhang 1B , Renfeng Luo 4AB*DOI: 10.12659/MSM.933449
Med Sci Monit 2022; 28:e933449
Figure 2 Forest plots for the association platelet to lymphocyte ratio and overall survival in patients with advanced gastric cancer (HR=1.429, 95% CI=1.246–1.639, P<0.001). CI – confidence interval; HR – hazard ratio.